The impact of hypertension on longitudinal cognitive decline in cognitively unimpaired individuals

Mid‐life hypertension (HTN) is considered a risk factor for the development of clinical Alzheimer´s Disease (AD). Yet, it is not known whether late‐life hypertension relates to AD´s pathophysiology, with current literature being contradictory. We recently demonstrated that a vascular risk factor composite, which includes HTN, interact with the AD pathophysiology to promote cognitive decline. Here, we aimed to assess whether late‐life HTN alone and AD biomarkers interact to promote longitudinal cognitive decline, and if controlling the blood pressure affects this relationship.